Delivering the Production You Need — With the Service You Want
Whether you’re looking for small volumes of material to continue your clinical trials or large-scale production for a global commercial therapy, you’ll find Emergent CDMO a highly committed, capable, and consistent partner across all phases of the product life cycle.
Emergent CDMO provides your team with the full suite of cGMP-compliant development processes across viral and non-viral platforms and complex formulation types such as suspensions, viscous solutions, lyophilization optimization, as well as products with stability challenges. We bolster every technology advantage we deliver with efficient tech transfer, proven regulatory compliance experience, and the kind of customer experience that has allowed us to be a trusted partner for the development and manufacture of more than 40 commercial products and 200-plus clinical candidates.
- Recombinant proteins
- Monoclonal antibodies
- Plasmid DNA
- Small molecules
- Plasma protein therapeutics